Eurobio Scientific SA (ALERS)

Currency in EUR
24.95
-0.15(-0.60%)
Closed·
ALERS Scorecard
Full Analysis
Net income is expected to grow this year
ALERS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
23.9025.15
52 wk Range
23.2026.50
Key Statistics
Prev. Close
25.1
Open
25.1
Day's Range
23.9-25.15
52 wk Range
23.2-26.5
Volume
595
Average Volume (3m)
844
1-Year Change
1.42%
Book Value / Share
17.81
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALERS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
30.00
Upside
+20.24%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Eurobio Scientific SA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Eurobio Scientific SA Company Profile

Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and cancer. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, a molecular test for the surveillance of heart-transplant patients; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the evaluation of patients’ immune status against tetanus; and EBX molecular biology family, which includes a range of tests for identifying various pathogens responsible for infectious diseases and assessing the magnitude of the infection. The company also develops other diagnostic products using molecular biology. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.

Employees
326
Market
France

Compare ALERS to Peers and Sector

Metrics to compare
ALERS
Peers
Sector
Relationship
P/E Ratio
62.6x−2.4x−0.5x
PEG Ratio
−6.650.070.00
Price/Book
1.4x1.4x2.6x
Price / LTM Sales
1.6x8.1x3.3x
Upside (Analyst Target)
20.2%183.8%43.4%
Fair Value Upside
Unlock6.6%7.1%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 30.00
(+20.24% Upside)

Earnings

Latest Release
Apr 28, 2025
EPS / Forecast
-- / --
Revenue / Forecast
40.75M / --
EPS Revisions
Last 90 days

ALERS Income Statement

People Also Watch

252.90
ESLX
+0.28%
70.32
TEPRF
-0.20%
21.77
STMPA
+1.92%
616.90
ASML
+1.02%
229.00
TCFP
-0.95%

FAQ

What Stock Exchange Does Eurobio Scientific Trade On?

Eurobio Scientific is listed and trades on the Paris Stock Exchange stock exchange.

What Is the Stock Symbol for Eurobio Scientific?

The stock symbol for Eurobio Scientific is "ALERS."

What Is the Eurobio Scientific Market Cap?

As of today, Eurobio Scientific market cap is 250.36M.

What Is Eurobio Scientific's Earnings Per Share (TTM)?

The Eurobio Scientific EPS (TTM) is 0.39.

From a Technical Analysis Perspective, Is ALERS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Eurobio Scientific Stock Split?

Eurobio Scientific has split 1 times.

How Many Employees Does Eurobio Scientific Have?

Eurobio Scientific has 326 employees.

What is the current trading status of Eurobio Scientific (ALERS)?

As of 10 Aug 2025, Eurobio Scientific (ALERS) is trading at a price of 24.95, with a previous close of 25.10. The stock has fluctuated within a day range of 23.90 to 25.15, while its 52-week range spans from 23.20 to 26.50.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.